It seems some companies invent something and then put it on the shelf because they don't want other products or services to lose sales. NVO maybe developing a version of semaglutide to treat obesity that seems to work and prevent other very serious diseases that are very expensive to treat. Semaglutide has become very popular and sales of NVO's semaglutide in the USA are increasing and NVO can't keep up with production.
It was announced weeks ago that NVO is cutting it's advertising of their Wegovy version of semaglutide because their production can't keep up with demand. Yet, NVO is not saying much about expanding production. It looks to me like NVO isn't making an effort to develop their version of semaglutide.
I really wonder if NVO has put the product on the shelf because a lot of money is made off of obesity and many diseases related to obesity such as diabetes and heart diseases. I believe NVO could be like the next Microsoft or Apple is they'd make a serious effort to increase the production of semaglutide. Most people in the USA will be overweight or obese if a product such as semaglutide isn't developed and made available in the USA.
If VNO is putting semaglutide on the self, it seems we ought to have the right to take matters into our own hands. Companies in the USA should be given approval to develop versions of semaglutide because preventing obesity would save lives.
Apparently NVO is trying to sue, but they are not saying much about an effort to increase the production of semaglutide. So I hope it will be ruled that we can do something about obesity that works: Develop our own versions of semaglutide.
Disclusure: I don't know whether or not to buy NVO ADR.
Leave a Reply